John C. Kappes - Publications

Affiliations: 
University of Alabama, Birmingham, Birmingham, AL, United States 
Area:
Microbiology Biology

151 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Zhou R, Zhang S, Nguyen HT, Ding H, Gaffney A, Kappes JC, Smith AB, Sodroski JG. Conformations of Human Immunodeficiency Virus Envelope Glycoproteins in Detergents and Styrene-Maleic Acid Lipid Particles. Journal of Virology. e0032723. PMID 37255444 DOI: 10.1128/jvi.00327-23  0.345
2023 Wang K, Zhang S, Go EP, Ding H, Wang WL, Nguyen HT, Kappes JC, Desaire H, Sodroski J, Mao Y. Asymmetric conformations of cleaved HIV-1 envelope glycoprotein trimers in styrene-maleic acid lipid nanoparticles. Communications Biology. 6: 535. PMID 37202420 DOI: 10.1038/s42003-023-04916-w  0.361
2022 Anthony-Gonda K, Ray A, Su H, Wang Y, Xiong Y, Lee D, Block A, Chilunda V, Weiselberg J, Zemelko L, Wang YY, Kleinsorge-Block S, Reese JS, de Lima M, Ochsenbauer C, ... Kappes JC, et al. In vivo killing of primary HIV-infected cells by peripheral-injected early memory-enriched anti-HIV duoCAR T cells. Jci Insight. 7. PMID 36345941 DOI: 10.1172/jci.insight.161698  0.469
2022 Nguyen HT, Qualizza A, Anang S, Zhao M, Zou S, Zhou R, Wang Q, Zhang S, Deshpande A, Ding H, Chiu TJ, Smith AB, Kappes JC, Sodroski JG. Functional and Highly Cross-Linkable HIV-1 Envelope Glycoproteins Enriched in a Pretriggered Conformation. Journal of Virology. e0166821. PMID 35343783 DOI: 10.1128/jvi.01668-21  0.437
2022 Prévost J, Richard J, Gasser R, Medjahed H, Kirchhoff F, Hahn BH, Kappes JC, Ochsenbauer C, Duerr R, Finzi A. Detection of the HIV-1 accessory proteins Nef and Vpu by flow cytometry represents a new tool to study their functional interplay within a single infected CD4+ T cell. Journal of Virology. jvi0192921. PMID 35080425 DOI: 10.1128/jvi.01929-21  0.442
2021 Zhang S, Wang K, Wang WL, Nguyen HT, Chen S, Lu M, Go EP, Ding H, Steinbock RT, Desaire H, Kappes JC, Sodroski J, Mao Y. Asymmetric structures and conformational plasticity of the uncleaved full-length human immunodeficiency virus (HIV-1) envelope glycoprotein trimer. Journal of Virology. JVI0052921. PMID 34549974 DOI: 10.1128/JVI.00529-21  0.427
2020 Zhang S, Nguyen HT, Ding H, Wang J, Zou S, Liu L, Guha D, Gabuzda D, Ho DD, Kappes JC, Sodroski J. Dual pathways of human immunodeficiency virus (HIV-1) envelope glycoprotein trafficking modulate the selective exclusion of uncleaved oligomers from virions. Journal of Virology. PMID 33148792 DOI: 10.1128/JVI.01369-20  0.435
2020 Alam SM, Cronin K, Parks R, Anasti K, Ding H, Go EP, Desaire H, Eaton A, Montefiori D, Sodroski J, Kappes J, Haynes BF, Saunders KO. Antigenicity and Immunogenicity of HIV-1 Envelope Trimers complexed to a Small-Molecule Viral Entry Inhibitor. Journal of Virology. PMID 32817216 DOI: 10.1128/Jvi.00958-20  0.388
2020 Adland E, Millar J, Bengu N, Muenchhoff M, Fillis R, Sprenger K, Ntlantsana V, Roider J, Vieira V, Govender K, Adamson J, Nxele N, Ochsenbauer C, Kappes J, Mori L, et al. Author Correction: Sex-specific innate immune selection of HIV-1 in utero is associated with increased female susceptibility to infection. Nature Communications. 11: 2257. PMID 32367015 DOI: 10.1038/S41467-020-16215-7  0.419
2020 Adland E, Millar J, Bengu N, Muenchhoff M, Fillis R, Sprenger K, Ntlantsana V, Roider J, Vieira V, Govender K, Adamson J, Nxele N, Ochsenbauer C, Kappes J, Mori L, et al. Sex-specific innate immune selection of HIV-1 in utero is associated with increased female susceptibility to infection. Nature Communications. 11: 1767. PMID 32286302 DOI: 10.1038/S41467-020-15632-Y  0.466
2020 Zou S, Zhang S, Gaffney A, Ding H, Lu M, Grover JR, Farrell M, Nguyen HT, Zhao C, Anang S, Zhao M, Mohammadi M, Blanchard SC, Abrams C, Madani N, ... ... Kappes JC, et al. Long-Acting BMS-378806 Analogues Stabilize the State-1 Conformation of the Human Immunodeficiency Virus (HIV-1) Envelope Glycoproteins. Journal of Virology. PMID 32161177 DOI: 10.1128/Jvi.00148-20  0.522
2019 Mielke D, Bandawe G, Pollara J, Abrahams MR, Nyanhete T, Moore PL, Thebus R, Yates NL, Kappes JC, Ochsenbauer C, Garrett N, Abdool Karim S, Tomaras GD, Montefiori D, Morris L, et al. Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway. Frontiers in Immunology. 10: 2875. PMID 31921139 DOI: 10.3389/Fimmu.2019.02875  0.441
2019 Hertoghs N, Nijmeijer BM, van Teijlingen NH, Fenton-May AE, Kaptein TM, van Hamme JL, Kappes JC, Kootstra NA, Hahn BH, Borrow P, Ribeiro CMS, Geijtenbeek TBH. Sexually transmitted founder HIV-1 viruses are relatively resistant to Langerhans cell-mediated restriction. Plos One. 14: e0226651. PMID 31856198 DOI: 10.1371/Journal.Pone.0226651  0.504
2019 Wang C, Liu D, Zuo T, Hora B, Cai F, Ding H, Kappes J, Ochsenbauer C, Kong W, Yu X, Bhattacharya T, Perelson AS, Gao F. Accumulated mutations by 6 months of infection collectively render transmitted/founder HIV-1 significantly less fit. The Journal of Infection. PMID 31812703 DOI: 10.1016/J.Jinf.2019.12.001  0.512
2019 Anthony-Gonda K, Bardhi A, Ray A, Flerin N, Li M, Chen W, Ochsenbauer C, Kappes JC, Krueger W, Worden A, Schneider D, Zhu Z, Orentas R, Dimitrov DS, Goldstein H, et al. Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model. Science Translational Medicine. 11. PMID 31391322 DOI: 10.1126/Scitranslmed.Aav5685  0.568
2019 Thans TVS, Akko JI, Niehrs A, Garcia-Beltran WF, Richert L, Stürzel CM, Ford CT, Li H, Ochsenbauer C, Kappes JC, Hahn BH, Kirchhoff F, Martrus G, Sauter D, Altfeld M, et al. Primary HIV-1 strains use Nef to downmodulate HLA-E surface expression. Journal of Virology. PMID 31375574 DOI: 10.1128/Jvi.00719-19  0.501
2018 Prévost J, Richard J, Medjahed H, Alexander A, Jones J, Kappes JC, Ochsenbauer C, Finzi A. Incomplete downregulation of CD4 expression affects HIV-1 Env conformation and ADCC responses. Journal of Virology. PMID 29669829 DOI: 10.1128/Jvi.00484-18  0.47
2017 Xavier BM, Hildebrandt E, Jiang F, Ding H, Kappes JC, Urbatsch IL. Substitution of Yor1p NBD1 residues improves the thermal stability of Human Cystic Fibrosis Transmembrane Conductance Regulator. Protein Engineering, Design & Selection : Peds. 1-13. PMID 29053845 DOI: 10.1093/Protein/Gzx054  0.322
2017 Bardhi A, Wu Y, Chen W, Zhu Z, Zheng JH, Wong H, Jeng E, Jones J, Ochsenbauer C, Kappes JC, Dimitrov DS, Ying T, Goldstein H. Potent In Vivo NK Cell-mediated Elimination of HIV-1-Infected Cells Mobilized by a gp120-bispecific and Hexavalent Broadly Neutralizing Fusion Protein. Journal of Virology. PMID 28794022 DOI: 10.1128/Jvi.00937-17  0.576
2017 Bonsignori M, Kreider EF, Fera D, Meyerhoff RR, Bradley T, Wiehe K, Alam SM, Aussedat B, Walkowicz WE, Hwang KK, Saunders KO, Zhang R, Gladden MA, Monroe A, Kumar A, ... ... Kappes J, et al. Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodies. Science Translational Medicine. 9. PMID 28298420 DOI: 10.1126/Scitranslmed.Aai7514  0.489
2017 Yoder AC, Guo K, Dillon SM, Phang T, Lee EJ, Harper MS, Helm K, Kappes JC, Ochsenbauer C, McCarter MD, Wilson CC, Santiago ML. The transcriptome of HIV-1 infected intestinal CD4+ T cells exposed to enteric bacteria. Plos Pathogens. 13: e1006226. PMID 28241075 DOI: 10.1371/Journal.Ppat.1006226  0.548
2017 Nguyen HT, Madani N, Ding H, Elder E, Princiotto A, Gu C, Darby P, Alin J, Herschhorn A, Kappes JC, Mao Y, Sodroski JG. Evaluation of the contribution of the transmembrane region to the ectodomain conformation of the human immunodeficiency virus (HIV-1) envelope glycoprotein. Virology Journal. 14: 33. PMID 28209172 DOI: 10.1186/S12985-017-0704-X  0.502
2017 Go EP, Ding H, Zhang S, Ringe RP, Nicely N, Hua D, Steinbock RT, Golabek M, Alin J, Alam SM, Cupo A, Haynes BF, Kappes JC, Moore JP, Sodroski JG, et al. A glycosylation benchmark profile for HIV-1 envelope glycoprotein production based on eleven Env trimers. Journal of Virology. PMID 28202756 DOI: 10.1128/Jvi.02428-16  0.487
2017 Witt KC, Castillo-Menendez L, Ding H, Espy N, Zhang S, Kappes JC, Sodroski J. Antigenic characterization of the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor incorporated into nanodiscs. Plos One. 12: e0170672. PMID 28151945 DOI: 10.1371/Journal.Pone.0170672  0.514
2016 Huang Y, Ferrari G, Alter G, Forthal DN, Kappes JC, Lewis GK, Love JC, Borate B, Harris L, Greene K, Gao H, Phan TB, Landucci G, Goods BA, Dowell KG, et al. Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects. Journal of Immunology (Baltimore, Md. : 1950). 197: 4603-4612. PMID 27913647 DOI: 10.4049/Jimmunol.1601197  0.537
2016 Rodriguez-Garcia M, Shen Z, Barr FD, Boesch AW, Ackerman ME, Kappes JC, Ochsenbauer C, Wira CR. Dendritic cells from the human female reproductive tract rapidly capture and respond to HIV. Mucosal Immunology. PMID 27579858 DOI: 10.1038/Mi.2016.72  0.446
2016 Prasad R, Kappes JC, Katiyar SK. Inhibition of NADPH oxidase 1 activity and blocking the binding of cytosolic and membrane-bound proteins by honokiol inhibit migratory potential of melanoma cells. Oncotarget. PMID 26760964 DOI: 10.18632/Oncotarget.6860  0.312
2016 Thomas T, Seay K, Zheng JH, Zhang C, Ochsenbauer C, Kappes JC, Goldstein H. High-Throughput Humanized Mouse Models for Evaluation of HIV-1 Therapeutics and Pathogenesis. Methods in Molecular Biology (Clifton, N.J.). 1354: 221-35. PMID 26714715 DOI: 10.1007/978-1-4939-3046-3_15  0.548
2016 Rodriguez-Garcia M, Shen Z, Barr F, Rossoll R, Kappes J, Ochsenbauer C, Wira C. Dendritic cells from the human female reproductive tract rapidly capture HIV Journal of Reproductive Immunology. 115: 54. DOI: 10.1016/j.jri.2016.04.167  0.381
2015 Seay K, Khajoueinejad N, Zheng JH, Kiser P, Ochsenbauer C, Kappes JC, Herold B, Goldstein H. The Vaginal Acquisition and Dissemination of HIV-1 Infection in a Novel Transgenic Mouse Model Is Facilitated by Coinfection with Herpes Simplex Virus 2 and Is Inhibited by Microbicide Treatment. Journal of Virology. 89: 9559-70. PMID 26157126 DOI: 10.1128/Jvi.01326-15  0.555
2015 Alberti MO, Jones JJ, Miglietta R, Ding H, Bakshi RK, Edmonds TG, Kappes JC, Ochsenbauer C. Optimized Replicating Renilla Luciferase Reporter HIV-1 Utilizing Novel Internal Ribosome Entry Site Elements for Native Nef Expression and Function. Aids Research and Human Retroviruses. PMID 26101895 DOI: 10.1089/aid.2015.0074  0.835
2015 Go EP, Herschhorn A, Gu C, Castillo-Menendez L, Zhang S, Mao Y, Chen H, Ding H, Wakefield JK, Hua D, Liao HX, Kappes JC, Sodroski J, Desaire H. Comparative Analysis of the Glycosylation Profiles of Membrane-Anchored HIV-1 Envelope Glycoprotein Trimers and Soluble gp140. Journal of Virology. 89: 8245-57. PMID 26018173 DOI: 10.1128/Jvi.00628-15  0.44
2015 Seay K, Church C, Zheng JH, Deneroff K, Ochsenbauer C, Kappes JC, Liu B, Jeng EK, Wong HC, Goldstein H. In Vivo Activation of Human NK Cells by Treatment with an Interleukin-15 Superagonist Potently Inhibits Acute In Vivo HIV-1 Infection in Humanized Mice. Journal of Virology. 89: 6264-74. PMID 25833053 DOI: 10.1128/Jvi.00563-15  0.52
2015 Hildebrandt E, Ding H, Mulky A, Dai Q, Aleksandrov AA, Bajrami B, Diego PA, Wu X, Ray M, Naren AP, Riordan JR, Yao X, DeLucas LJ, Urbatsch IL, Kappes JC. Erratum to: A Stable Human-Cell System Overexpressing Cystic Fibrosis Transmembrane Conductance Regulator Recombinant Protein at the Cell Surface. Molecular Biotechnology. 57: 406. PMID 25808031 DOI: 10.1007/S12033-015-9857-2  0.767
2015 Hildebrandt E, Ding H, Mulky A, Dai Q, Aleksandrov AA, Bajrami B, Diego PA, Wu X, Ray M, Naren AP, Riordan JR, Yao X, DeLucas LJ, Urbatsch IL, Kappes JC. A stable human-cell system overexpressing cystic fibrosis transmembrane conductance regulator recombinant protein at the cell surface. Molecular Biotechnology. 57: 391-405. PMID 25577540 DOI: 10.1007/S12033-014-9830-5  0.765
2014 Baxter AE, Russell RA, Duncan CJ, Moore MD, Willberg CB, Pablos JL, Finzi A, Kaufmann DE, Ochsenbauer C, Kappes JC, Groot F, Sattentau QJ. Macrophage infection via selective capture of HIV-1-infected CD4+ T cells. Cell Host & Microbe. 16: 711-21. PMID 25467409 DOI: 10.1016/J.Chom.2014.10.010  0.529
2014 Sainski AM, Dai H, Natesampillai S, Pang YP, Bren GD, Cummins NW, Correia C, Meng XW, Tarara JE, Ramirez-Alvarado M, Katzmann DJ, Ochsenbauer C, Kappes JC, Kaufmann SH, Badley AD. Casp8p41 generated by HIV protease kills CD4 T cells through direct Bak activation. The Journal of Cell Biology. 206: 867-76. PMID 25246614 DOI: 10.1083/Jcb.201405051  0.552
2014 Shen R, Kappes JC, Smythies LE, Richter HE, Novak L, Smith PD. Vaginal myeloid dendritic cells transmit founder HIV-1. Journal of Virology. 88: 7683-8. PMID 24741097 DOI: 10.1128/Jvi.00766-14  0.486
2014 Sarzotti-Kelsoe M, Daniell X, Todd CA, Bilska M, Martelli A, LaBranche C, Perez LG, Ochsenbauer C, Kappes JC, Rountree W, Denny TN, Montefiori DC. Optimization and validation of a neutralizing antibody assay for HIV-1 in A3R5 cells. Journal of Immunological Methods. 409: 147-60. PMID 24607608 DOI: 10.1016/J.Jim.2014.02.013  0.525
2014 deCamp A, Hraber P, Bailer RT, Seaman MS, Ochsenbauer C, Kappes J, Gottardo R, Edlefsen P, Self S, Tang H, Greene K, Gao H, Daniell X, Sarzotti-Kelsoe M, Gorny MK, et al. Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies. Journal of Virology. 88: 2489-507. PMID 24352443 DOI: 10.1128/Jvi.02853-13  0.518
2014 Duncan CJ, Williams JP, Schiffner T, Gärtner K, Ochsenbauer C, Kappes J, Russell RA, Frater J, Sattentau QJ. High-multiplicity HIV-1 infection and neutralizing antibody evasion mediated by the macrophage-T cell virological synapse. Journal of Virology. 88: 2025-34. PMID 24307588 DOI: 10.1128/Jvi.03245-13  0.548
2014 Naarding MA, Fernandez N, Kappes JC, Hayes P, Ahmed T, Icyuz M, Edmonds TG, Bergin P, Anzala O, Hanke T, Clark L, Cox JH, Cormier E, Ochsenbauer C, Gilmour J. Development of a luciferase based viral inhibition assay to evaluate vaccine induced CD8 T-cell responses. Journal of Immunological Methods. 409: 161-73. PMID 24291126 DOI: 10.1016/J.Jim.2013.11.021  0.837
2014 Sainski AM, Dai H, Natesampillai S, Pang YP, Bren GD, Cummins NW, Correia C, Wei Meng X, Tarara JE, Ramirez-Alvarado M, Katzmann DJ, Ochsenbauer C, Kappes JC, Kaufmann SH, Badley AD. Correction to Casp8p41 generated by HIV protease kills CD4 T cells through direct Bak activation [Journal of Cell Biology, 206, 7, (2014), 867-876] Journal of Cell Biology. 207: 159. DOI: 10.1083/Jcb.20140505109252014C  0.484
2013 McLinden RJ, Labranche CC, Chenine AL, Polonis VR, Eller MA, Wieczorek L, Ochsenbauer C, Kappes JC, Perfetto S, Montefiori DC, Michael NL, Kim JH. Detection of HIV-1 neutralizing antibodies in a human CD4⁺/CXCR4⁺/CCR5⁺ T-lymphoblastoid cell assay system. Plos One. 8: e77756. PMID 24312168 DOI: 10.1371/Journal.Pone.0077756  0.546
2013 Chenine AL, Wieczorek L, Sanders-Buell E, Wesberry M, Towle T, Pillis DM, Molnar S, McLinden R, Edmonds T, Hirsch I, O'Connell R, McCutchan FE, Montefiori DC, Ochsenbauer C, Kappes JC, et al. Impact of HIV-1 backbone on neutralization sensitivity: neutralization profiles of heterologous envelope glycoproteins expressed in native subtype C and CRF01_AE backbone. Plos One. 8: e76104. PMID 24312165 DOI: 10.1371/Journal.Pone.0076104  0.829
2013 Fenton-May AE, Dibben O, Emmerich T, Ding H, Pfafferott K, Aasa-Chapman MM, Pellegrino P, Williams I, Cohen MS, Gao F, Shaw GM, Hahn BH, Ochsenbauer C, Kappes JC, Borrow P. Relative resistance of HIV-1 founder viruses to control by interferon-alpha. Retrovirology. 10: 146. PMID 24299076 DOI: 10.1186/1742-4690-10-146  0.525
2013 Seay K, Qi X, Zheng JH, Zhang C, Chen K, Dutta M, Deneroff K, Ochsenbauer C, Kappes JC, Littman DR, Goldstein H. Mice transgenic for CD4-specific human CD4, CCR5 and cyclin T1 expression: a new model for investigating HIV-1 transmission and treatment efficacy. Plos One. 8: e63537. PMID 23691059 DOI: 10.1371/Journal.Pone.0063537  0.524
2013 Liu P, Yates NL, Shen X, Bonsignori M, Moody MA, Liao HX, Fong Y, Alam SM, Overman RG, Denny T, Ferrari G, Ochsenbauer C, Kappes JC, Polonis VR, Pitisuttithum P, et al. Infectious virion capture by HIV-1 gp120-specific IgG from RV144 vaccinees. Journal of Virology. 87: 7828-36. PMID 23658446 DOI: 10.1128/Jvi.02737-12  0.505
2013 Parrish NF, Gao F, Li H, Giorgi EE, Barbian HJ, Parrish EH, Zajic L, Iyer SS, Decker JM, Kumar A, Hora B, Berg A, Cai F, Hopper J, Denny TN, ... ... Kappes JC, et al. Phenotypic properties of transmitted founder HIV-1. Proceedings of the National Academy of Sciences of the United States of America. 110: 6626-33. PMID 23542380 DOI: 10.1073/Pnas.1304288110  0.542
2013 King DF, Siddiqui AA, Buffa V, Fischetti L, Gao Y, Stieh D, McKay PF, Rogers P, Ochsenbauer C, Kappes JC, Arts EJ, Shattock RJ. Mucosal tissue tropism and dissemination of HIV-1 subtype B acute envelope-expressing chimeric virus. Journal of Virology. 87: 890-9. PMID 23135721 DOI: 10.1128/Jvi.02216-12  0.513
2013 Baalwa J, Wang S, Parrish NF, Decker JM, Keele BF, Learn GH, Yue L, Ruzagira E, Ssemwanga D, Kamali A, Amornkul PN, Price MA, Kappes JC, Karita E, Kaleebu P, et al. Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones. Virology. 436: 33-48. PMID 23123038 DOI: 10.1016/J.Virol.2012.10.009  0.488
2013 Denning W, Das S, Guo S, Xu J, Kappes JC, Hel Z. Optimization of the transductional efficiency of lentiviral vectors: effect of sera and polycations. Molecular Biotechnology. 53: 308-14. PMID 22407723 DOI: 10.1007/S12033-012-9528-5  0.301
2013 Borrow P, Stacey A, Fenton-May A, Dibben O, Haygreen E, Emmerich T, Kim N, Marshall E, Lavender K, Cohen M, Goepfert P, Williams I, Wallace D, Shaw G, Hahn B, ... ... Kappes J, et al. Innate immune responses in acute HIV-1 infection: protective or pathogenic? Retrovirology. 10. DOI: 10.1186/1742-4690-10-S1-O33  0.451
2013 Parrish NF, Li H, Hora B, Berg A, Wilen CB, Decker J, Iyer SS, Zajic L, O’Brien M, Salazar-Gonzalez JF, Salazar MG, Parrish EH, Ding H, Kumar A, Ochsenbauer C, ... ... Kappes JC, et al. C106 Distinguishing Features of Transmitted/Founder HIV-1 Jaids Journal of Acquired Immune Deficiency Syndromes. 62: S45. DOI: 10.1097/01.Qai.0000429225.92253.36  0.462
2012 Merbah M, Arakelyan A, Edmonds T, Ochsenbauer C, Kappes JC, Shattock RJ, Grivel JC, Margolis LB. HIV-1 expressing the envelopes of transmitted/founder or control/reference viruses have similar infection patterns of CD4 T-cells in human cervical tissue ex vivo. Plos One. 7: e50839. PMID 23236398 DOI: 10.1371/Journal.Pone.0050839  0.835
2012 Shishido T, Wolschendorf F, Duverger A, Wagner F, Kappes J, Jones J, Kutsch O. Selected drugs with reported secondary cell-differentiating capacity prime latent HIV-1 infection for reactivation. Journal of Virology. 86: 9055-69. PMID 22696646 DOI: 10.1128/Jvi.00793-12  0.512
2012 Parrish NF, Wilen CB, Banks LB, Iyer SS, Pfaff JM, Salazar-Gonzalez JF, Salazar MG, Decker JM, Parrish EH, Berg A, Hopper J, Hora B, Kumar A, Mahlokozera T, Yuan S, ... ... Kappes JC, et al. Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7 Plos Pathogens. 8. PMID 22693444 DOI: 10.1371/Journal.Ppat.1002686  0.506
2012 Lahey T, Ghosh M, Fahey JV, Shen Z, Mukura LR, Song Y, Cu-Uvin S, Mayer KH, Wright PF, Kappes JC, Ochsenbauer C, Wira CR. Selective impact of HIV disease progression on the innate immune system in the human female reproductive tract. Plos One. 7: e38100. PMID 22675510 DOI: 10.1371/Journal.Pone.0038100  0.511
2012 Smalls-Mantey A, Doria-Rose N, Klein R, Patamawenu A, Migueles SA, Ko SY, Hallahan CW, Wong H, Liu B, You L, Scheid J, Kappes JC, Ochsenbauer C, Nabel GJ, Mascola JR, et al. Antibody-dependent cellular cytotoxicity against primary HIV-infected CD4+ T cells is directly associated with the magnitude of surface IgG binding. Journal of Virology. 86: 8672-80. PMID 22674985 DOI: 10.1128/Jvi.00287-12  0.579
2012 Montefiori DC, Karnasuta C, Huang Y, Ahmed H, Gilbert P, de Souza MS, McLinden R, Tovanabutra S, Laurence-Chenine A, Sanders-Buell E, Moody MA, Bonsignori M, Ochsenbauer C, Kappes J, Tang H, et al. Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials. The Journal of Infectious Diseases. 206: 431-41. PMID 22634875 DOI: 10.1093/Infdis/Jis367  0.507
2012 Freel SA, Picking RA, Ferrari G, Ding H, Ochsenbauer C, Kappes JC, Kirchherr JL, Soderberg KA, Weinhold KJ, Cunningham CK, Denny TN, Crump JA, Cohen MS, McMichael AJ, Haynes BF, et al. Initial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replication. Journal of Virology. 86: 6835-46. PMID 22514337 DOI: 10.1128/Jvi.00437-12  0.503
2012 Brown BK, Wieczorek L, Kijak G, Lombardi K, Currier J, Wesberry M, Kappes JC, Ngauy V, Marovich M, Michael N, Ochsenbauer C, Montefiori DC, Polonis VR. The role of natural killer (NK) cells and NK cell receptor polymorphisms in the assessment of HIV-1 neutralization. Plos One. 7: e29454. PMID 22509241 DOI: 10.1371/Journal.Pone.0029454  0.512
2012 Ochsenbauer C, Edmonds TG, Ding H, Keele BF, Decker J, Salazar MG, Salazar-Gonzalez JF, Shattock R, Haynes BF, Shaw GM, Hahn BH, Kappes JC. Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages. Journal of Virology. 86: 2715-28. PMID 22190722 DOI: 10.1128/Jvi.06157-11  0.817
2012 Dietrich EA, Gebhard KH, Fasching CE, Giacaman RA, Kappes JC, Ross KF, Herzberg MC. Short communication: HIV type 1 escapes inactivation by saliva via rapid escape into oral epithelial cells. Aids Research and Human Retroviruses. 28: 1574-8. PMID 22077822 DOI: 10.1089/Aid.2011.0069  0.543
2012 Sarzotti-Kelsoe M, Daniell X, Todd C, Bilska M, LaBranche C, Perez L, Ochsenbauer C, Kappes J, Rountree W, Ozaki D, Kim J, McLinden R, Denny T, Montefiori D. Optimization and validation of the HIV-1 neutralizing antibody assay in A3R5 cells. Retrovirology. 9: 69. DOI: 10.1186/1742-4690-9-S2-P69  0.491
2012 Jain S, Ochsenbauer C, Kappes J, Rosenthal K. Anti-gp41 antibodies inhibit infection and transcytosis of HIV-1 infectious molecular clones expressing transmitted/founder envelopes Retrovirology. 9: 195. DOI: 10.1186/1742-4690-9-S2-P195  0.563
2012 Williams W, Jones K, Krambrink A, Grove D, Liu P, Yates N, Moody M, Ferrari G, Pollara J, Moodie Z, Morgan C, Liao H, Montefiori D, Ochsenbauer C, Kappes J, et al. Multiple antibody specificities (gp41, V1V2, and V3) elicited in the phase II multiclade (A, B, C) HIV-1 DNA prime, rAd5 boost vaccine trial Retrovirology. 9. DOI: 10.1186/1742-4690-9-S2-O55  0.377
2012 Pollara J, Bonsignori M, Moody M, Alam M, Liao H, Hwang K, Pickeral J, Kappes J, Ochsenbauer C, Soderberg K, Gurley T, Kozink D, Marshall D, Whitesides J, Montefiori D, et al. Vaccine-induced ADCC-mediating antibodies target unique and overlapping envelope epitopes Retrovirology. 9: 1-1. DOI: 10.1186/1742-4690-9-S2-O39  0.358
2012 Seay K, Qi X, Zheng J, Dutta M, Ochsenbauer C, Kappes J, Santambrogio L, Littman D, Goldstein H. GM-CSF treatment enables mice transgenic for CD4-specific expression of human CD4, CCR5 and CyclinT1 to support in vitro and in vivo HIV infection Journal of Reproductive Immunology. 94: 128-129. DOI: 10.1016/J.Jri.2012.03.484  0.413
2012 Edmonds TG, Ochsenbauer C, Ding H, Grivel J-, Shen R, Smith PD, Margolis L, Kappes JC. Transmitted/founder virus infectivity in cells derived from blood and female reproductive tract tissue Journal of Reproductive Immunology. 94: 128. DOI: 10.1016/J.Jri.2012.03.483  0.775
2011 Liu P, Overman RG, Yates NL, Alam SM, Vandergrift N, Chen Y, Graw F, Freel SA, Kappes JC, Ochsenbauer C, Montefiori DC, Gao F, Perelson AS, Cohen MS, Haynes BF, et al. Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection. Journal of Virology. 85: 11196-207. PMID 21865397 DOI: 10.1128/Jvi.05601-11  0.509
2011 Forthal DN, Landucci G, Ding H, Kappes JC, Wang A, Thung I, Phan T. IgG2 inhibits HIV-1 internalization by monocytes, and IgG subclass binding is affected by gp120 glycosylation. Aids (London, England). 25: 2099-104. PMID 21832933 DOI: 10.1097/Qad.0B013E32834B64Bd  0.392
2011 Pollara J, Hart L, Brewer F, Pickeral J, Packard BZ, Hoxie JA, Komoriya A, Ochsenbauer C, Kappes JC, Roederer M, Huang Y, Weinhold KJ, Tomaras GD, Haynes BF, Montefiori DC, et al. High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. 79: 603-12. PMID 21735545 DOI: 10.1002/Cyto.A.21084  0.537
2011 Shen R, Meng G, Ochsenbauer C, Clapham PR, Grams J, Novak L, Kappes JC, Smythies LE, Smith PD. Stromal down-regulation of macrophage CD4/CCR5 expression and NF-κB activation mediates HIV-1 non-permissiveness in intestinal macrophages. Plos Pathogens. 7: e1002060. PMID 21637819 DOI: 10.1371/Journal.Ppat.1002060  0.509
2011 Ferrari G, Pollara J, Kozink D, Harms T, Drinker M, Freel S, Moody MA, Alam SM, Tomaras GD, Ochsenbauer C, Kappes JC, Shaw GM, Hoxie JA, Robinson JE, Haynes BF. An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum. Journal of Virology. 85: 7029-36. PMID 21543485 DOI: 10.1128/Jvi.00171-11  0.532
2011 Yang M, Li Y, Chilukuri K, Brady OA, Boulos MI, Kappes JC, Galileo DS. L1 stimulation of human glioma cell motility correlates with FAK activation. Journal of Neuro-Oncology. 105: 27-44. PMID 21373966 DOI: 10.1007/S11060-011-0557-X  0.301
2011 Groot F, Russell RA, Baxter AE, Welsch S, Duncan CJ, Willberg C, Ochsenbauer C, Kappes JC, Shaw M, Sattentau QJ. Efficient macrophage infection by phagocytosis of dying HIV-1 -infected CD4+T cells Retrovirology. 8: 1-2. DOI: 10.1186/1742-4690-8-S2-O31  0.497
2010 Ochiel DO, Ochsenbauer C, Kappes JC, Ghosh M, Fahey JV, Wira CR. Uterine epithelial cell regulation of DC-SIGN expression inhibits transmitted/founder HIV-1 trans infection by immature dendritic cells. Plos One. 5: e14306. PMID 21179465 DOI: 10.1371/Journal.Pone.0014306  0.516
2010 Edmonds TG, Ding H, Yuan X, Wei Q, Smith KS, Conway JA, Wieczorek L, Brown B, Polonis V, West JT, Montefiori DC, Kappes JC, Ochsenbauer C. Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC. Virology. 408: 1-13. PMID 20863545 DOI: 10.1016/J.Virol.2010.08.028  0.847
2010 Bartoszewski RA, Jablonsky M, Bartoszewska S, Stevenson L, Dai Q, Kappes J, Collawn JF, Bebok Z. A synonymous single nucleotide polymorphism in DeltaF508 CFTR alters the secondary structure of the mRNA and the expression of the mutant protein. The Journal of Biological Chemistry. 285: 28741-8. PMID 20628052 DOI: 10.1074/Jbc.M110.154575  0.305
2010 Ghosh M, Fahey JV, Shen Z, Lahey T, Cu-Uvin S, Wu Z, Mayer K, Wright PF, Kappes JC, Ochsenbauer C, Wira CR. Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies. Plos One. 5: e11366. PMID 20614007 DOI: 10.1371/Journal.Pone.0011366  0.523
2010 Moody MA, Liao HX, Alam SM, Scearce RM, Plonk MK, Kozink DM, Drinker MS, Zhang R, Xia SM, Sutherland LL, Tomaras GD, Giles IP, Kappes JC, Ochsenbauer-Jambor C, Edmonds TG, et al. Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce beta-chemokines. The Journal of Experimental Medicine. 207: 763-76. PMID 20368576 DOI: 10.1084/Jem.20091281  0.828
2010 Geonnotti AR, Bilska M, Yuan X, Ochsenbauer C, Edmonds TG, Kappes JC, Liao HX, Haynes BF, Montefiori DC. Differential inhibition of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and TZM-bl cells by endotoxin-mediated chemokine and gamma interferon production. Aids Research and Human Retroviruses. 26: 279-91. PMID 20218881 DOI: 10.1089/Aid.2009.0186  0.826
2010 Shen R, Drelichman ER, Bimczok D, Ochsenbauer C, Kappes JC, Cannon JA, Tudor D, Bomsel M, Smythies LE, Smith PD. GP41-specific antibody blocks cell-free HIV type 1 transcytosis through human rectal mucosa and model colonic epithelium. Journal of Immunology (Baltimore, Md. : 1950). 184: 3648-55. PMID 20208001 DOI: 10.4049/Jimmunol.0903346  0.568
2010 Cella M, Presti R, Vermi W, Lavender K, Turnbull E, Ochsenbauer-Jambor C, Kappes JC, Ferrari G, Kessels L, Williams I, McMichael AJ, Haynes BF, Borrow P, Colonna M, et al. Loss of DNAM-1 contributes to CD8+ T-cell exhaustion in chronic HIV-1 infection. European Journal of Immunology. 40: 949-54. PMID 20201043 DOI: 10.1002/Eji.200940234  0.473
2010 Freel SA, Lamoreaux L, Chattopadhyay PK, Saunders K, Zarkowsky D, Overman RG, Ochsenbauer C, Edmonds TG, Kappes JC, Cunningham CK, Denny TN, Weinhold KJ, Ferrari G, Haynes BF, Koup RA, et al. Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime/boost vaccination. Journal of Virology. 84: 4998-5006. PMID 20200250 DOI: 10.1128/Jvi.00138-10  0.832
2009 Ochsenbauer C, Kappes JC. New virologic reagents for neutralizing antibody assays. Current Opinion in Hiv and Aids. 4: 418-25. PMID 20048706 DOI: 10.1097/Coh.0B013E32832F011E  0.399
2009 Sauter D, Schindler M, Specht A, Landford WN, Münch J, Kim KA, Votteler J, Schubert U, Bibollet-Ruche F, Keele BF, Takehisa J, Ogando Y, Ochsenbauer C, Kappes JC, Ayouba A, et al. Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. Cell Host & Microbe. 6: 409-21. PMID 19917496 DOI: 10.1016/J.Chom.2009.10.004  0.524
2009 Matyas GR, Wieczorek L, Beck Z, Ochsenbauer-Jambor C, Kappes JC, Michael NL, Polonis VR, Alving CR. Neutralizing antibodies induced by liposomal HIV-1 glycoprotein 41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes. Aids (London, England). 23: 2069-77. PMID 19710597 DOI: 10.1097/Qad.0B013E32832Faea5  0.452
2009 Salazar-Gonzalez JF, Salazar MG, Keele BF, Learn GH, Giorgi EE, Li H, Decker JM, Wang S, Baalwa J, Kraus MH, Parrish NF, Shaw KS, Guffey MB, Bar KJ, Davis KL, ... ... Kappes JC, et al. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. The Journal of Experimental Medicine. 206: 1273-89. PMID 19487424 DOI: 10.1084/Jem.20090378  0.554
2009 Liu Y, Shah SV, Xiang X, Wang J, Deng ZB, Liu C, Zhang L, Wu J, Edmonds T, Jambor C, Kappes JC, Zhang HG. COP9-associated CSN5 regulates exosomal protein deubiquitination and sorting. The American Journal of Pathology. 174: 1415-25. PMID 19246649 DOI: 10.2353/Ajpath.2009.080861  0.778
2009 Matyas GR, Wieczorek L, Beck Z, Ochsenbauer-Jambor C, Kappes JC, Michael NL, Polonis VR, Alving CR. P05-04. Neutralizing antibodies induced by immunization with liposomal gp41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes Retrovirology. 6: P80. DOI: 10.1186/1742-4690-6-S3-P80  0.366
2009 Wieczorek L, Brown BK, Wesberry M, Ochsenbauer-Jambor C, Kappes JC, Lora N, Gillis A, Nzodom C, Molnar S, Michael NL, Montefiori D, Polonis VR. P04-23. HIV-1 neutralization is impacted by the PBMC donor used for both virus growth and target cells, and the effects are neutralization reagent-specific Retrovirology. 6: P51. DOI: 10.1186/1742-4690-6-S3-P51  0.527
2009 Brown BK, Lombardi K, Bryson M, Currier J, Thelian D, Wieczorek L, Kijak G, Kappes JC, Ochsenbauer-Jambor C, Michael NL, Montefiori D, Polonis VR. P04-12. Characterization of leukopak PBMC phenotypes and biotypes for optimal performance in HIV-1 neutralization assays Retrovirology. 6: P40. DOI: 10.1186/1742-4690-6-S3-P40  0.455
2009 Siddiqui AA, King DF, Buffa V, Fischetti L, Ochsenbauer-Jambor C, Gao Y, Krebs KC, Kappes JC, Arts EJ, Shattock RJ. P20-15. Evaluation of HIV-1 subtype B acute envelope-expressing infectious molecular clones Retrovirology. 6. DOI: 10.1186/1742-4690-6-S3-P385  0.498
2009 Freel SA, Chattopadhyay PK, Lamoreaux L, Zarkowsky D, Overman RG, Ochsenbauer-Jambor C, Kappes JC, Cunningham CK, Denny TN, Weinhold KJ, Ferrari G, Koup RA, Graham BS, Haynes BF, Roederer M, et al. S01-04 OA. Phenotypic analyses of CD8+ T cells that mediate virus inhibition from HIV-1 vaccinees and HIV-1+ virus controllers Retrovirology. 6: O1. DOI: 10.1186/1742-4690-6-S3-O1  0.325
2009 Ochiel D, Ghosh M, Fahey J, Kappes J, Ochsenbauer-Jambor C, Guyre P, Wira C. Regulation of Immature Dendritic Cells HIV-1 Infectivity by Uterine Epithelial Cell-Derived Transforming Growth Factor Beta (TGFβ) Journal of Reproductive Immunology. 81: 173. DOI: 10.1016/J.Jri.2009.06.251  0.446
2009 Ghosh M, Fahey J, Shen Z, Cu-Uvin S, Mayer K, Wu Z, Kappes J, Ochsenbauer-Jambor C, Wright P, Wira C. Cervical-vaginal lavages from HIV positive- and HIV negative-women contain immune factors that have intrinsic anti-HIV activity Journal of Reproductive Immunology. 81: 172-173. DOI: 10.1016/J.Jri.2009.06.250  0.404
2007 Bansal A, Yue L, Conway J, Yusim K, Tang J, Kappes J, Kaslow RA, Wilson CM, Goepfert PA. Immunological control of chronic HIV-1 infection: HLA-mediated immune function and viral evolution in adolescents. Aids (London, England). 21: 2387-97. PMID 18025875 DOI: 10.1097/Qad.0B013E3282F13823  0.465
2007 Olivares I, Mulky A, Boross PI, Tözsér J, Kappes JC, López-Galíndez C, Menéndez-Arias L. HIV-1 protease dimer interface mutations that compensate for viral reverse transcriptase instability in infectious virions. Journal of Molecular Biology. 372: 369-81. PMID 17651754 DOI: 10.1016/J.Jmb.2007.06.073  0.828
2007 Luo K, Wang T, Liu B, Tian C, Xiao Z, Kappes J, Yu XF. Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation. Journal of Virology. 81: 7238-48. PMID 17428847 DOI: 10.1128/Jvi.02584-06  0.476
2007 Mulky A, Vu BC, Conway JA, Hughes SH, Kappes JC. Analysis of amino acids in the beta7-beta8 loop of human immunodeficiency virus type 1 reverse transcriptase for their role in virus replication. Journal of Molecular Biology. 365: 1368-78. PMID 17141805 DOI: 10.1016/J.Jmb.2006.10.089  0.785
2006 Chou CF, Mulky A, Maitra S, Lin WJ, Gherzi R, Kappes J, Chen CY. Tethering KSRP, a decay-promoting AU-rich element-binding protein, to mRNAs elicits mRNA decay. Molecular and Cellular Biology. 26: 3695-706. PMID 16648466 DOI: 10.1128/Mcb.26.10.3695-3706.2006  0.756
2005 Mulky A, Kappes JC. Analysis of human immunodeficiency virus type 1 reverse transcriptase subunit structure/function in the context of infectious virions and human target cells. Antimicrobial Agents and Chemotherapy. 49: 3762-9. PMID 16127051 DOI: 10.1128/Aac.49.9.3762-3769.2005  0.819
2005 Mulky A, Sarafianos SG, Jia Y, Arnold E, Kappes JC. Identification of amino acid residues in the human immunodeficiency virus type-1 reverse transcriptase tryptophan-repeat motif that are required for subunit interaction using infectious virions. Journal of Molecular Biology. 349: 673-84. PMID 15893326 DOI: 10.1016/J.Jmb.2005.03.057  0.798
2004 Daniel R, Greger JG, Katz RA, Taganov KD, Wu X, Kappes JC, Skalka AM. Evidence that stable retroviral transduction and cell survival following DNA integration depend on components of the nonhomologous end joining repair pathway. Journal of Virology. 78: 8573-81. PMID 15280466 DOI: 10.1128/Jvi.78.16.8573-8581.2004  0.385
2004 Mulky A, Sarafianos SG, Arnold E, Wu X, Kappes JC. Subunit-specific analysis of the human immunodeficiency virus type 1 reverse transcriptase in vivo. Journal of Virology. 78: 7089-96. PMID 15194785 DOI: 10.1128/Jvi.78.13.7089-7096.2004  0.811
2003 Padow M, Lai L, Deivanayagam C, DeLucas LJ, Weiss RB, Dunn DM, Wu X, Kappes JC. Replication of chimeric human immunodeficiency virus type 1 (HIV-1) containing HIV-2 integrase (IN): naturally selected mutations in IN augment DNA synthesis. Journal of Virology. 77: 11050-9. PMID 14512553 DOI: 10.1128/Jvi.77.20.11050-11059.2003  0.805
2003 Wei X, Decker JM, Wang S, Hui H, Kappes JC, Wu X, Salazar-Gonzalez JF, Salazar MG, Kilby JM, Saag MS, Komarova NL, Nowak MA, Hahn BH, Kwong PD, Shaw GM. Antibody neutralization and escape by HIV-1. Nature. 422: 307-12. PMID 12646921 DOI: 10.1038/Nature01470  0.538
2003 Wei X, Decker JM, Wang S, Hui H, Kappes JC, Wu X, Salazar-Gonzalez JF, Salazar MG, Michael Kilby J, Saag MS, Komarova NL, Nowak MA, Hahn BH, Kwong PD, Shaw GM. Erratum: Antibody neutralization and escape by HIV-1 Nature. 423: 197-197. DOI: 10.1038/Nature01565  0.411
2002 Wei X, Decker JM, Liu H, Zhang Z, Arani RB, Kilby JM, Saag MS, Wu X, Shaw GM, Kappes JC. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrobial Agents and Chemotherapy. 46: 1896-905. PMID 12019106 DOI: 10.1128/Aac.46.6.1896-1905.2002  0.487
2002 Shehu-Xhilaga M, Hill M, Marshall JA, Kappes J, Crowe SM, Mak J. The conformation of the mature dimeric human immunodeficiency virus type 1 RNA genome requires packaging of pol protein. Journal of Virology. 76: 4331-40. PMID 11932399 DOI: 10.1128/Jvi.76.9.4331-4340.2002  0.405
2002 Noya F, Chien WM, Wu X, Banerjee NS, Kappes JC, Broker TR, Chow LT. The promoter of the human proliferating cell nuclear antigen gene is not sufficient for cell cycle-dependent regulation in organotypic cultures of keratinocytes. The Journal of Biological Chemistry. 277: 17271-80. PMID 11877408 DOI: 10.1074/Jbc.M112441200  0.32
2002 Meng G, Wei X, Wu X, Sellers MT, Decker JM, Moldoveanu Z, Orenstein JM, Graham MF, Kappes JC, Mestecky J, Shaw GM, Smith PD. Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells. Nature Medicine. 8: 150-6. PMID 11821899 DOI: 10.1038/Nm0202-150  0.499
2001 Kappes JC, Wu X. Safety considerations in vector development Somatic Cell and Molecular Genetics. 26: 147-158. PMID 12465466 DOI: 10.1023/A:1021082815013  0.386
2001 Lai L, Liu H, Wu X, Kappes JC. Moloney murine leukemia virus integrase protein augments viral DNA synthesis in infected cells Journal of Virology. 75: 11365-11372. PMID 11689617 DOI: 10.1128/Jvi.75.23.11365-11372.2001  0.411
2001 Yung E, Sorin M, Pal A, Craig E, Morozov A, Delattre O, Kappes J, Ott D, Kalpana GV. Inhibition of HIV-1 virion production by a transdominant mutant of integrase interactor 1. Nature Medicine. 7: 920-6. PMID 11479624 DOI: 10.1038/90959  0.541
2000 Padow M, Lai L, Fisher RJ, Yu Chun Zhou, Wu X, Kappes JC, Towler EM. Analysis of human immunodeficiency virus type 1 containing HERV-K protease Aids Research and Human Retroviruses. 16: 1973-1980. PMID 11153080 DOI: 10.1089/088922200750054701  0.793
2000 Chen W, Wu X, Levasseur DN, Liu H, Lai L, Kappes JC, Townes TM. Lentiviral vector transduction of hematopoietic stem cells that mediate long-term reconstitution of lethally irradiated mice Stem Cells. 18: 352-359. PMID 11007919 DOI: 10.1634/Stemcells.18-5-352  0.314
2000 Derdeyn CA, Decker JM, Sfakianos JN, Wu X, O'Brien WA, Ratner L, Kappes JC, Shaw GM, Hunter E. Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. Journal of Virology. 74: 8358-67. PMID 10954535 DOI: 10.1128/Jvi.74.18.8358-8367.2000  0.386
2000 Wu X, Wakefield JK, Liu H, Xiao H, Kralovics R, Prchal JT, Kappes JC. Development of a novel trans-lentiviral vector that affords predictable safety Molecular Therapy. 2: 47-55. PMID 10899827 DOI: 10.1006/Mthe.2000.0095  0.477
1999 Liu H, Wu X, Xiao H, Kappes JC. Targeting human immunodeficiency virus (HIV) type 2 integrase protein into HIV type 1 Journal of Virology. 73: 8831-8836. PMID 10482639 DOI: 10.1128/Jvi.73.10.8831-8836.1999  0.586
1999 Wu X, Liu H, Xiao H, Conway JA, Hehl E, Kalpana GV, Prasad V, Kappes JC. Human immunodeficiency virus type 1 integrase protein promotes reverse transcription through specific interactions with the nucleoprotein reverse transcription complex Journal of Virology. 73: 2126-2135. PMID 9971795 DOI: 10.1128/Jvi.73.3.2126-2135.1999  0.512
1997 Liu H, Wu X, Xiao H, Conway JA, Kappes JC. Incorporation of functional human immunodeficiency virus type 1 integrase into virions independent of the Gag-Pol precursor protein Journal of Virology. 71: 7704-7710. PMID 9311854 DOI: 10.1128/Jvi.71.10.7704-7710.1997  0.486
1997 Wu X, Liu H, Xiao H, Conway JA, Hunter E, Kappes JC. Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein Embo Journal. 16: 5113-5122. PMID 9305652 DOI: 10.1093/Emboj/16.16.5113  0.546
1996 Xiaoyun WU, Liu H, Xiao H, Conway JA, Kappes JC. Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease-mutant fusion protein into viral particles Journal of Virology. 70: 3378-3384. PMID 8648668 DOI: 10.1128/Jvi.70.6.3378-3384.1996  0.547
1996 Wu X, Liu H, Xiao H, Kappes JC. Proteolytic activity of human immunodeficiency virus Vpr-and Vpx-protease fusion proteins Virology. 219: 307-313. PMID 8623547 DOI: 10.1006/Viro.1996.0253  0.558
1995 Newman MA, McPherson SA, Fletcher TM, Kappes JC, Hahn BH. Polyclonal rabbit antisera that detect the Vpr protein of SIVSM and SIVMAC on immunoblots of purified virions. Aids Research and Human Retroviruses. 11: 405-8. PMID 7786585 DOI: 10.1089/Aid.1995.11.405  0.437
1995 Wu X, Liu H, Xiao H, Kim J, Seshaiah P, Natsoulis G, Boeke JD, Hahn BH, Kappes JC. Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx Journal of Virology. 69: 3389-3398. PMID 7745685 DOI: 10.1128/Jvi.69.6.3389-3398.1995  0.55
1995 Kappes JC. Viral protein X Current Topics in Microbiology and Immunology. 193: 121-132. PMID 7648872 DOI: 10.1007/978-3-642-78929-8_7  0.505
1995 Kappes JC, Saag MS, Shaw GM, Hahn BH, Chopra P, Chen S, Emini EA, McFarland R, Yang LC, Piatak M, Lifson JD. Assessment of antiretroviral therapy by plasma viral load testing: Standard and ICD HIV-1 p24 antigen and viral RNA (QC-PCR) assays compared Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 10: 139-149. PMID 7552477 DOI: 10.1097/00042560-199510020-00005  0.475
1995 Liu H, Wu X, Newman M, Shaw GM, Hahn BH, Kappes JC. The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures Journal of Virology. 69: 7630-7638. PMID 7494271 DOI: 10.1128/Jvi.69.12.7630-7638.1995  0.573
1994 Wu X, Conway JA, Kim J, Kappes JC. Localization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 Gag precursor protein Journal of Virology. 68: 6161-6169. PMID 8083957 DOI: 10.1128/Jvi.68.10.6161-6169.1994  0.587
1993 Kappes JC, Parkin JS, Conway JA, Kim J, Brouillette CG, Shaw GM, Hahn BH. Intracellular Transport and Virion Incorporation of vpx Requires Interaction with Other Virus Type-Specific Components Virology. 193: 222-233. PMID 8438567 DOI: 10.1006/Viro.1993.1118  0.581
1993 Lee TH, Stromberg RR, Henrard D, Busch MP, Piatak M, Shaw GM, Yang LC, Kappes JC, Saag MS, Lifson JD. Effect of platelet-associated virus on assays of HIV-1 in plasma Science. 262: 1585-1586. PMID 8248811  0.379
1993 Piatak M, Yang LC, Luk KC, Lifson JD, Saag MS, Clark SJ, Kappes JC, Hahn BH, Shaw GM. Viral dynamics in primary HIV-1 infection [21] Lancet. 341: 1099. PMID 8097000 DOI: 10.1016/0140-6736(93)92463-4  0.517
1993 Piatak M, Saag MS, Yang LC, Clark SJ, Kappes JC, Luk KC, Hahn BH, Shaw GM, Lifson JD. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR Science. 259: 1749-1754. PMID 8096089  0.406
1993 Piatak M, Saag MS, Yang LC, Clark SJ, Kappes JC, Luk KC, Hahn BH, Shaw GM, Lifson JD. Determination of plasma viral load in HIV-1 infection by quantitative competitive polymerase chain reaction Aids. 7. PMID 7909227 DOI: 10.1097/00002030-199311002-00014  0.481
1993 Saag MS, Emini EA, Laskin OL, Douglas J, Lapidus WI, Schleif WA, Whitley RJ, Hildebrand C, Byrnes VW, Kappes JC, Anderson KW, Massari FE, Shaw GM. A short-term clinical evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase New England Journal of Medicine. 329: 1065-1072. PMID 7690462 DOI: 10.1056/Nejm199310073291502  0.44
1993 Piatak M, Luk KC, Saag MS, Kappes JC, Yang LC, Lifson JD, Clark SJ, Hahn BH, Shaw GM. Viral dynamics in primary HIV-1 infection The Lancet. 341: 1099. DOI: 10.1016/0140-6736(93)92463-4  0.422
1991 Clark SJ, Saag MS, Decker WD, Campbell-Hill S, Roberson JL, Veldkamp PJ, Kappes JC, Hahn BH, Shaw GM. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection New England Journal of Medicine. 324: 954-960. PMID 1900576 DOI: 10.1056/Nejm199104043241404  0.553
1991 Li Y, Kappes JC, Conway JA, Price RW, Shaw GM, Hahn BH. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: Identification of replication-competent and -defective viral genomes Journal of Virology. 65: 3973-3985. PMID 1830110 DOI: 10.1128/Jvi.65.8.3973-3985.1991  0.501
1991 Kappes JC, Conway JA, Lee SW, Shaw GM, Hahn BH. Human immunodeficiency virus type 2 vpx protein augments viral infectivity Virology. 184: 197-209. PMID 1714662 DOI: 10.1016/0042-6822(91)90836-Z  0.606
1990 Kumar P, Hui H, Kappes JC, Haggarty BS, Hoxie JA, Arya SK, Shaw GM, Hahn BH. Molecular characterization of an attenuated human immunodeficiency virus type 2 isolate Journal of Virology. 64: 890-901. PMID 2296086 DOI: 10.1128/Jvi.64.2.890-901.1990  0.53
1988 Kong LI, Lee SW, Kappes JC, Parkin JS, Decker D, Hoxie JA, Hahn BH, Shaw GM. West African HIV-2-related human retrovirus with attenuated cytopathicity Science. 240: 1525-1529. PMID 3375832 DOI: 10.1126/Science.3375832  0.59
1988 Kappes JC, Morrow CD, Lee SW, Jameson BA, Kent SB, Hood LE, Shaw GM, Hahn BH. Identification of a novel retroviral gene unique to human immunodeficiency virus type 2 and simian immunodeficiency virus SIVMAC. Journal of Virology. 62: 3501-5. PMID 3136256 DOI: 10.1128/Jvi.62.9.3501-3505.1988  0.56
1988 Bernstein DI, Stanberry LR, Kappes JC, Burke RL, Myers MG. Antibody to herpes simplex virus (Hsv) icp-35 proteins after hsv challenge of animals immunized with hsv subunit vaccines Journal of Infectious Diseases. 157: 1178-1186. PMID 2836519 DOI: 10.1093/Infdis/157.6.1178  0.347
1988 Bernstein DI, Kappes JC. Enhanced in vitro reactivation of latent herpes simplex virus from neural and peripheral tissues with hexamethylenebisacetamide Archives of Virology. 99: 57-65. PMID 2833203 DOI: 10.1007/Bf01311023  0.343
1988 Stephanopoulos DE, Kappes JC, Bernstein DI. Enhanced in vitro reactivation of herpes simplex virus type 2 from latency infected guinea-pig neural tissues by 5-azacytidine Journal of General Virology. 69: 1079-1083. PMID 2453606 DOI: 10.1099/0022-1317-69-5-1079  0.386
1987 Bernstein DI, Stanberry LR, Harrison CJ, Shukla R, Kappes JC, Myers MG. Antibody Response to Herpes Simplex Virus Glycoprotein d: Effects of Acyclovir and Relation to Recurrence Journal of Infectious Diseases. 156: 423-429. PMID 3039009 DOI: 10.1093/Infdis/156.3.423  0.3
1986 Bernstein DI, Stanberry LR, Harrison CJ, Kappes JC, Myers MG. Antibody response, recurrence patterns and subsequent herpes simplex virus type 2 (HSV-2) re-infection following initial HSV-2 infection of guinea-pigs: Effects of acyclovir Journal of General Virology. 67: 1601-1612. PMID 3016155 DOI: 10.1099/0022-1317-67-8-1601  0.351
Show low-probability matches.